1. Home
  2. Companies
  3. IXC
  4. Announcements

Invex Therapeutics (ASX:IXC)

ASX announcement history & article coverage

3
Total announcements
(in last 3 months)
2
With article
1
No article
Article coverage
67%
Transparent by design. Announcments by Invex Therapeutics (ASX:IXC) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

31 Aug 2026 · 07:18 pm AEST ASX Filing
Appendix 4G and Corporate Governance Statement
Corporate GovernanceAppendix 4G
31 Aug 2026 · 07:17 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Appendix 4E and Annual Report to shareholders
Invex Therapeutics reports $1.35M loss for FY2026 driven by R&D expansion and collaboration with Tessara Therapeutics
Annual ReportTop 20 shareholders
60
Invex Therapeutics Reports $1.35M Loss as Alzheimer’s Research Intensifies

23 July 2026 · 06:14 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activities/Appendix 4C Cash Flow Report
Invex Therapeutics expands Alzheimer's preclinical research; Q4 FY26 cash falls to $4.02M with higher R&D spend
Commitments Test Entity - Fourth Quarter Activity ReportCommitments Test Entity - Fourth Quarter Cashflow Report
50
Invex Therapeutics Expands Alzheimer’s Research Amid Rising R&D Spend and $4M Cash Reserve Healthcare Wrap - Week 30 (20 July -> 24 July) 2026 Wrap